Thanks to four decades of investment by diverse groups, data drawn from more than 300,000 critically ill patients around the world have been used to develop ICU scoring systems (1). The investments have produced well-validated and contemporary iterations of severity scores, including the Acute Physiology and Chronic Health Evaluation (APACHE), the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model, among several others (2) (3) (4) (5) . In addition, numerous follow-on studies have compared how these scores perform in new patient subgroups or care settings (1, 6) . The verdict is in; critical care is fortunate to have an abundance of excellent options.
In light of what could be considered an embarrassment of riches, how can we thus maximize the benefits of new investments in scoring system development? A natural inclination would aim to further improve the precision of outcome model predictions, a goal that seems well aligned with leveraging individual variability to direct precision medicine (7) . However, the benefits of such an investment may be limited for several reasons. First, despite the improved performance of contemporary iterations of ICU severity scores, their older versions seem good enough-scores developed in the 1980s persist even in the highest profile studies (8) . Second, outcome prediction models were designed to be applied to populations of patients and may have limited utility when applied to individual patients (1) . Thus, despite our lengthy history with ICU scoring systems, we still lack any examples where these severity scores are used to direct treatments. Finally, greatly improved precision-for example, the ability to reliably discriminate between a 42% and 48% risk of developing shock-may have limited incremental benefit when there are only a few treatment options.
In this issue of Critical Care Medicine, Williams et al (9) offers one potential way forward: choose parsimony. Clinical data were prospectively collected from 8,871 Australian patients treated in the emergency department with presumed infection. The corresponding infection severity was categorized as infection without systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic shock. The discrimination of severity score models with respect to mortality were then compared, including the Mortality in Emergency Department Sepsis (MEDS), the Sequential Organ Failure Assessment, the Severe Sepsis Score, the APACHE II, and the SAPS 2 scores. In the overall cohort, the MEDS, SAPS, and APACHE scores all displayed exquisite discrimination for predicting mortality (c-statistics 0.90-0.92 with overlapping CIs), likely owing to the relative health of the sample-53% of patients did not meet SIRS criteria. In all severity comparisons, the MEDS score displayed the highest discrimination. As expected, calibration was poor for the APACHE and SAPSscores initially developed for critically ill patients in the 1980s.
Although the study firmly supports the use of simpler scoring systems, it highlights relevant challenges as well. To its credit, the MEDS reduces the number of variables needed to produce a score from 16 (APACHE II) or 17 (SAPS 2) to 9. However, many of the left-out variables in other scoring systems are routinely available for most patients (e.g., heart rate and sodium). Thus, if used at the point of care, it is arguable whether the MEDS would actually translate into a decrease in a clinician's workload. For the purposes of population comparisons for research or risk adjustment, the MEDS introduces new variables with heterogeneous availability and reliability (e.g., rapidly terminal comorbid illness and nursing home resident). What the MEDS does offer is a greatly simplified point assignment system where only one value is assigned if an abnormality is present (e.g., three points for tachypnea or hypoxia).
In light of its equivalent or superior discrimination in sepsis patients, choosing parsimony with the MEDS seems a reasonable choice; however, parsimony alone is not itself a worthy goal. In an age in which microprocessors vastly outperform humans in computational speed, power, and reliability, we should harness complex informatics to simplify the prognostic and treatment decision making of clinicians (10, 11) . Novel approaches leveraging machine learning to identify the highest risk sepsis patients earlier in their clinical course show promising results (12) . Furthermore, many efforts are underway to employ computers to offload the work of iteratively computing risk scores or performing pattern recognition in thousands of hospitalized patients in real time (13) (14) (15) . When deployed within this longitudinal framework, even relatively simplistic scores are likely to demonstrate considerably improved utility and more favorable signal-to-noise ratios.
The grand vision is a living and breathing healthcare information infrastructure, which proactively identifies patients in whom targeted and timely interventions can substantially improve the quality and outcomes of care. However, this vision has yet to be realized. Perhaps in an ironic twist, even the most cutting-edge approaches have so far produced prediction models that look nearly identical to those already standardized decades ago. Fortunately, while we wait for our turn in the data revolution, when it comes to severity scoring in critical care, we still have an abundance of excellent options.
